{"description":"Documents published on or after 10/01/2026 and from Drug Enforcement Administration","count":37,"total_pages":2,"next_page_url":"https://www.federalregister.gov/api/v1/documents?conditions%5Bagencies%5D%5B%5D=drug-enforcement-administration&conditions%5Bpublication_date%5D%5Bgte%5D=2026-10-01&format=json&page=2&search_after_cursor=WzE3OTIzNjgwMDAwMDAsIjIwMjYtMjEzNTQiXQ","results":[{"title":"Bulk Manufacturer of Controlled Substances Application: AJNA Biosciences","type":"Notice","abstract":"AJNA Biosciences has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.","document_number":"2026-22289","html_url":"https://www.federalregister.gov/documents/2026/11/02/2026-22289/bulk-manufacturer-of-controlled-substances-application-ajna-biosciences","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2026-11-02/pdf/2026-22289.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2026-22289.pdf?1793364312","publication_date":"2026-11-02","agencies":[{"raw_name":"DEPARTMENT OF JUSTICE","name":"Justice Department","id":268,"url":"https://www.federalregister.gov/agencies/justice-department","json_url":"https://www.federalregister.gov/api/v1/agencies/268","parent_id":null,"slug":"justice-department"},{"raw_name":"Drug Enforcement Administration","name":"Drug Enforcement Administration","id":116,"url":"https://www.federalregister.gov/agencies/drug-enforcement-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/116","parent_id":268,"slug":"drug-enforcement-administration"}],"excerpts":"AJNA Biosciences has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information."},{"title":"Importer of Controlled Substances Application: Globyz Pharma LLC","type":"Notice","abstract":"Globyz Pharma LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.","document_number":"2026-22288","html_url":"https://www.federalregister.gov/documents/2026/11/02/2026-22288/importer-of-controlled-substances-application-globyz-pharma-llc","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2026-11-02/pdf/2026-22288.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2026-22288.pdf?1793364312","publication_date":"2026-11-02","agencies":[{"raw_name":"DEPARTMENT OF JUSTICE","name":"Justice Department","id":268,"url":"https://www.federalregister.gov/agencies/justice-department","json_url":"https://www.federalregister.gov/api/v1/agencies/268","parent_id":null,"slug":"justice-department"},{"raw_name":"Drug Enforcement Administration","name":"Drug Enforcement Administration","id":116,"url":"https://www.federalregister.gov/agencies/drug-enforcement-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/116","parent_id":268,"slug":"drug-enforcement-administration"}],"excerpts":"Globyz Pharma LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information."},{"title":"Conforming Amendment Regarding the Criminal Law Technical Amendments Act of 2002","type":"Rule","abstract":"The Criminal Law Technical Amendments Act of 2002 (\"Technical Amendments Act\") became law on November 2, 2002, as part of the 21st Century Department of Justice Appropriations Authorization Act. The Technical Amendments Act amended sections 401(d), 402(c), and 403 of the Controlled Substances Act by replacing outmoded fine amounts with a reference to title 18 of the United States Code in each place that a specific fine amount had appeared. In this rulemaking, the Drug Enforcement Administration (DEA) is amending its regulations to conform them to the statutory amendments made to the Controlled Substances Act by the Technical Amendments Act.","document_number":"2026-22285","html_url":"https://www.federalregister.gov/documents/2026/11/02/2026-22285/conforming-amendment-regarding-the-criminal-law-technical-amendments-act-of-2002","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2026-11-02/pdf/2026-22285.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2026-22285.pdf?1793364311","publication_date":"2026-11-02","agencies":[{"raw_name":"DEPARTMENT OF JUSTICE","name":"Justice Department","id":268,"url":"https://www.federalregister.gov/agencies/justice-department","json_url":"https://www.federalregister.gov/api/v1/agencies/268","parent_id":null,"slug":"justice-department"},{"raw_name":"Drug Enforcement Administration","name":"Drug Enforcement Administration","id":116,"url":"https://www.federalregister.gov/agencies/drug-enforcement-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/116","parent_id":268,"slug":"drug-enforcement-administration"}],"excerpts":"The Criminal Law Technical Amendments Act of 2002 (\"Technical Amendments Act\") became law on November 2, 2002, as part of the 21st Century Department of Justice Appropriations Authorization Act. The Technical Amendments Act amended sections 401(d),..."},{"title":"Schedules of Controlled Substances: Placement of Centanafadine in Schedule III","type":"Rule","abstract":"On July 24, 2026, the United States Food and Drug Administration (FDA) approved a new drug application for Simtriyo (centanafadine) for the treatment of attention-deficit/hyperactivity disorder in adults and pediatric patients aged 6 years and older, weighing at least 20 kg. The Department of Health and Human Services provided the Drug Enforcement Administration (DEA) with a scheduling recommendation to place centanafadine, chemically known as (1R,5S)-1- (naphthalen-2-yl)-3-azabicyclo[3.1.0]hexane, in schedule III of the Controlled Substances Act (CSA). In accordance with the CSA, as amended by the Improving Regulatory Transparency for New Medical Therapies Act, DEA is hereby issuing an interim final rule placing centanafadine, including its salts, isomers (whether optical, positional, or geometric), and salts of such isomers whenever the existence of such salts, isomers, and salts of isomers is possible in schedule III of the CSA.","document_number":"2026-22208","html_url":"https://www.federalregister.gov/documents/2026/10/30/2026-22208/schedules-of-controlled-substances-placement-of-centanafadine-in-schedule-iii","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2026-10-30/pdf/2026-22208.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2026-22208.pdf?1793277918","publication_date":"2026-10-30","agencies":[{"raw_name":"DEPARTMENT OF JUSTICE","name":"Justice Department","id":268,"url":"https://www.federalregister.gov/agencies/justice-department","json_url":"https://www.federalregister.gov/api/v1/agencies/268","parent_id":null,"slug":"justice-department"},{"raw_name":"Drug Enforcement Administration","name":"Drug Enforcement Administration","id":116,"url":"https://www.federalregister.gov/agencies/drug-enforcement-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/116","parent_id":268,"slug":"drug-enforcement-administration"}],"excerpts":"On July 24, 2026, the United States Food and Drug Administration (FDA) approved a new drug application for Simtriyo (centanafadine) for the treatment of attention-deficit/hyperactivity disorder in adults and pediatric patients aged 6 years and older,..."},{"title":"Bulk Manufacturer of Controlled Substances Application: Sigma Aldrich Research Biochemicals, Inc.","type":"Notice","abstract":"Sigma Aldrich Research Biochemicals, Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.","document_number":"2026-22048","html_url":"https://www.federalregister.gov/documents/2026/10/29/2026-22048/bulk-manufacturer-of-controlled-substances-application-sigma-aldrich-research-biochemicals-inc","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2026-10-29/pdf/2026-22048.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2026-22048.pdf?1793191513","publication_date":"2026-10-29","agencies":[{"raw_name":"DEPARTMENT OF JUSTICE","name":"Justice Department","id":268,"url":"https://www.federalregister.gov/agencies/justice-department","json_url":"https://www.federalregister.gov/api/v1/agencies/268","parent_id":null,"slug":"justice-department"},{"raw_name":"Drug Enforcement Administration","name":"Drug Enforcement Administration","id":116,"url":"https://www.federalregister.gov/agencies/drug-enforcement-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/116","parent_id":268,"slug":"drug-enforcement-administration"}],"excerpts":"Sigma Aldrich Research Biochemicals, Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information."},{"title":"Vida Janson, M.D.; Decision and Order","type":"Notice","abstract":null,"document_number":"2026-21799","html_url":"https://www.federalregister.gov/documents/2026/10/26/2026-21799/vida-janson-md-decision-and-order","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2026-10-26/pdf/2026-21799.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2026-21799.pdf?1792759518","publication_date":"2026-10-26","agencies":[{"raw_name":"DEPARTMENT OF JUSTICE","name":"Justice Department","id":268,"url":"https://www.federalregister.gov/agencies/justice-department","json_url":"https://www.federalregister.gov/api/v1/agencies/268","parent_id":null,"slug":"justice-department"},{"raw_name":"Drug Enforcement Administration","name":"Drug Enforcement Administration","id":116,"url":"https://www.federalregister.gov/agencies/drug-enforcement-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/116","parent_id":268,"slug":"drug-enforcement-administration"}],"excerpts":null},{"title":"Barry Backiewicz, D.D.S.; Decision and Order","type":"Notice","abstract":null,"document_number":"2026-21725","html_url":"https://www.federalregister.gov/documents/2026/10/26/2026-21725/barry-backiewicz-dds-decision-and-order","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2026-10-26/pdf/2026-21725.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2026-21725.pdf?1792759510","publication_date":"2026-10-26","agencies":[{"raw_name":"DEPARTMENT OF JUSTICE","name":"Justice Department","id":268,"url":"https://www.federalregister.gov/agencies/justice-department","json_url":"https://www.federalregister.gov/api/v1/agencies/268","parent_id":null,"slug":"justice-department"},{"raw_name":"Drug Enforcement Administration","name":"Drug Enforcement Administration","id":116,"url":"https://www.federalregister.gov/agencies/drug-enforcement-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/116","parent_id":268,"slug":"drug-enforcement-administration"}],"excerpts":null},{"title":"Peter Michael Wills, D.D.S.; Decision and Order","type":"Notice","abstract":null,"document_number":"2026-21415","html_url":"https://www.federalregister.gov/documents/2026/10/20/2026-21415/peter-michael-wills-dds-decision-and-order","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2026-10-20/pdf/2026-21415.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2026-21415.pdf?1792413912","publication_date":"2026-10-20","agencies":[{"raw_name":"DEPARTMENT OF JUSTICE","name":"Justice Department","id":268,"url":"https://www.federalregister.gov/agencies/justice-department","json_url":"https://www.federalregister.gov/api/v1/agencies/268","parent_id":null,"slug":"justice-department"},{"raw_name":"Drug Enforcement Administration","name":"Drug Enforcement Administration","id":116,"url":"https://www.federalregister.gov/agencies/drug-enforcement-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/116","parent_id":268,"slug":"drug-enforcement-administration"}],"excerpts":null},{"title":"Jan Pijanowski, M.D.; Decision and Order","type":"Notice","abstract":null,"document_number":"2026-21414","html_url":"https://www.federalregister.gov/documents/2026/10/20/2026-21414/jan-pijanowski-md-decision-and-order","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2026-10-20/pdf/2026-21414.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2026-21414.pdf?1792413912","publication_date":"2026-10-20","agencies":[{"raw_name":"DEPARTMENT OF JUSTICE","name":"Justice Department","id":268,"url":"https://www.federalregister.gov/agencies/justice-department","json_url":"https://www.federalregister.gov/api/v1/agencies/268","parent_id":null,"slug":"justice-department"},{"raw_name":"Drug Enforcement Administration","name":"Drug Enforcement Administration","id":116,"url":"https://www.federalregister.gov/agencies/drug-enforcement-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/116","parent_id":268,"slug":"drug-enforcement-administration"}],"excerpts":null},{"title":"Jefferson Burroughs, M.D.; Decision and Order","type":"Notice","abstract":null,"document_number":"2026-21413","html_url":"https://www.federalregister.gov/documents/2026/10/20/2026-21413/jefferson-burroughs-md-decision-and-order","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2026-10-20/pdf/2026-21413.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2026-21413.pdf?1792413912","publication_date":"2026-10-20","agencies":[{"raw_name":"DEPARTMENT OF JUSTICE","name":"Justice Department","id":268,"url":"https://www.federalregister.gov/agencies/justice-department","json_url":"https://www.federalregister.gov/api/v1/agencies/268","parent_id":null,"slug":"justice-department"},{"raw_name":"Drug Enforcement Administration","name":"Drug Enforcement Administration","id":116,"url":"https://www.federalregister.gov/agencies/drug-enforcement-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/116","parent_id":268,"slug":"drug-enforcement-administration"}],"excerpts":null},{"title":"Youmna Abdulhadi, M.D.; Decision and Order","type":"Notice","abstract":null,"document_number":"2026-21410","html_url":"https://www.federalregister.gov/documents/2026/10/20/2026-21410/youmna-abdulhadi-md-decision-and-order","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2026-10-20/pdf/2026-21410.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2026-21410.pdf?1792413912","publication_date":"2026-10-20","agencies":[{"raw_name":"DEPARTMENT OF JUSTICE","name":"Justice Department","id":268,"url":"https://www.federalregister.gov/agencies/justice-department","json_url":"https://www.federalregister.gov/api/v1/agencies/268","parent_id":null,"slug":"justice-department"},{"raw_name":"Drug Enforcement Administration","name":"Drug Enforcement Administration","id":116,"url":"https://www.federalregister.gov/agencies/drug-enforcement-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/116","parent_id":268,"slug":"drug-enforcement-administration"}],"excerpts":null},{"title":"Importer of Controlled Substances Application: Organic Standards Solutions International, LLC","type":"Notice","abstract":"Organic Standards Solutions International, LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.","document_number":"2026-21370","html_url":"https://www.federalregister.gov/documents/2026/10/19/2026-21370/importer-of-controlled-substances-application-organic-standards-solutions-international-llc","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2026-10-19/pdf/2026-21370.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2026-21370.pdf?1792154726","publication_date":"2026-10-19","agencies":[{"raw_name":"DEPARTMENT OF JUSTICE","name":"Justice Department","id":268,"url":"https://www.federalregister.gov/agencies/justice-department","json_url":"https://www.federalregister.gov/api/v1/agencies/268","parent_id":null,"slug":"justice-department"},{"raw_name":"Drug Enforcement Administration","name":"Drug Enforcement Administration","id":116,"url":"https://www.federalregister.gov/agencies/drug-enforcement-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/116","parent_id":268,"slug":"drug-enforcement-administration"}],"excerpts":"Organic Standards Solutions International, LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information."},{"title":"Bulk Manufacturer of Controlled Substances Application: Janssen Pharmaceuticals, Inc.","type":"Notice","abstract":"Janssen Pharmaceuticals, Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.","document_number":"2026-21369","html_url":"https://www.federalregister.gov/documents/2026/10/19/2026-21369/bulk-manufacturer-of-controlled-substances-application-janssen-pharmaceuticals-inc","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2026-10-19/pdf/2026-21369.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2026-21369.pdf?1792154726","publication_date":"2026-10-19","agencies":[{"raw_name":"DEPARTMENT OF JUSTICE","name":"Justice Department","id":268,"url":"https://www.federalregister.gov/agencies/justice-department","json_url":"https://www.federalregister.gov/api/v1/agencies/268","parent_id":null,"slug":"justice-department"},{"raw_name":"Drug Enforcement Administration","name":"Drug Enforcement Administration","id":116,"url":"https://www.federalregister.gov/agencies/drug-enforcement-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/116","parent_id":268,"slug":"drug-enforcement-administration"}],"excerpts":"Janssen Pharmaceuticals, Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information."},{"title":"Bulk Manufacturer of Controlled Substances Application: Groff Health Inc","type":"Notice","abstract":"Groff Health Inc has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.","document_number":"2026-21368","html_url":"https://www.federalregister.gov/documents/2026/10/19/2026-21368/bulk-manufacturer-of-controlled-substances-application-groff-health-inc","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2026-10-19/pdf/2026-21368.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2026-21368.pdf?1792154726","publication_date":"2026-10-19","agencies":[{"raw_name":"DEPARTMENT OF JUSTICE","name":"Justice Department","id":268,"url":"https://www.federalregister.gov/agencies/justice-department","json_url":"https://www.federalregister.gov/api/v1/agencies/268","parent_id":null,"slug":"justice-department"},{"raw_name":"Drug Enforcement Administration","name":"Drug Enforcement Administration","id":116,"url":"https://www.federalregister.gov/agencies/drug-enforcement-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/116","parent_id":268,"slug":"drug-enforcement-administration"}],"excerpts":"Groff Health Inc has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information."},{"title":"Importer of Controlled Substances Application: Groff NA Hemplex LLC","type":"Notice","abstract":"Groff NA Hemplex LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.","document_number":"2026-21367","html_url":"https://www.federalregister.gov/documents/2026/10/19/2026-21367/importer-of-controlled-substances-application-groff-na-hemplex-llc","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2026-10-19/pdf/2026-21367.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2026-21367.pdf?1792154726","publication_date":"2026-10-19","agencies":[{"raw_name":"DEPARTMENT OF JUSTICE","name":"Justice Department","id":268,"url":"https://www.federalregister.gov/agencies/justice-department","json_url":"https://www.federalregister.gov/api/v1/agencies/268","parent_id":null,"slug":"justice-department"},{"raw_name":"Drug Enforcement Administration","name":"Drug Enforcement Administration","id":116,"url":"https://www.federalregister.gov/agencies/drug-enforcement-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/116","parent_id":268,"slug":"drug-enforcement-administration"}],"excerpts":"Groff NA Hemplex LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information."},{"title":"Bulk Manufacturer of Controlled Substances Application: Scottsdale Research Institute","type":"Notice","abstract":"Scottsdale Research Institute has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.","document_number":"2026-21360","html_url":"https://www.federalregister.gov/documents/2026/10/19/2026-21360/bulk-manufacturer-of-controlled-substances-application-scottsdale-research-institute","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2026-10-19/pdf/2026-21360.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2026-21360.pdf?1792154725","publication_date":"2026-10-19","agencies":[{"raw_name":"DEPARTMENT OF JUSTICE","name":"Justice Department","id":268,"url":"https://www.federalregister.gov/agencies/justice-department","json_url":"https://www.federalregister.gov/api/v1/agencies/268","parent_id":null,"slug":"justice-department"},{"raw_name":"Drug Enforcement Administration","name":"Drug Enforcement Administration","id":116,"url":"https://www.federalregister.gov/agencies/drug-enforcement-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/116","parent_id":268,"slug":"drug-enforcement-administration"}],"excerpts":"Scottsdale Research Institute has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information."},{"title":"Bulk Manufacturer of Controlled Substances Application: National Center for Natural Products Research University of Mississippi/NCNPR","type":"Notice","abstract":"National Center for Natural Products Research University of Mississippi/NCNPR has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.","document_number":"2026-21359","html_url":"https://www.federalregister.gov/documents/2026/10/19/2026-21359/bulk-manufacturer-of-controlled-substances-application-national-center-for-natural-products-research","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2026-10-19/pdf/2026-21359.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2026-21359.pdf?1792154725","publication_date":"2026-10-19","agencies":[{"raw_name":"DEPARTMENT OF JUSTICE","name":"Justice Department","id":268,"url":"https://www.federalregister.gov/agencies/justice-department","json_url":"https://www.federalregister.gov/api/v1/agencies/268","parent_id":null,"slug":"justice-department"},{"raw_name":"Drug Enforcement Administration","name":"Drug Enforcement Administration","id":116,"url":"https://www.federalregister.gov/agencies/drug-enforcement-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/116","parent_id":268,"slug":"drug-enforcement-administration"}],"excerpts":"National Center for Natural Products Research University of Mississippi/NCNPR has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information."},{"title":"Importer of Controlled Substances Application: National Center for Natural Products Research","type":"Notice","abstract":"National Center for Natural Products Research has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.","document_number":"2026-21358","html_url":"https://www.federalregister.gov/documents/2026/10/19/2026-21358/importer-of-controlled-substances-application-national-center-for-natural-products-research","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2026-10-19/pdf/2026-21358.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2026-21358.pdf?1792154725","publication_date":"2026-10-19","agencies":[{"raw_name":"DEPARTMENT OF JUSTICE","name":"Justice Department","id":268,"url":"https://www.federalregister.gov/agencies/justice-department","json_url":"https://www.federalregister.gov/api/v1/agencies/268","parent_id":null,"slug":"justice-department"},{"raw_name":"Drug Enforcement Administration","name":"Drug Enforcement Administration","id":116,"url":"https://www.federalregister.gov/agencies/drug-enforcement-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/116","parent_id":268,"slug":"drug-enforcement-administration"}],"excerpts":"National Center for Natural Products Research has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information."},{"title":"Importer of Controlled Substances Application: Groff Health Inc.","type":"Notice","abstract":"Groff Health Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.","document_number":"2026-21355","html_url":"https://www.federalregister.gov/documents/2026/10/19/2026-21355/importer-of-controlled-substances-application-groff-health-inc","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2026-10-19/pdf/2026-21355.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2026-21355.pdf?1792154724","publication_date":"2026-10-19","agencies":[{"raw_name":"DEPARTMENT OF JUSTICE","name":"Justice Department","id":268,"url":"https://www.federalregister.gov/agencies/justice-department","json_url":"https://www.federalregister.gov/api/v1/agencies/268","parent_id":null,"slug":"justice-department"},{"raw_name":"Drug Enforcement Administration","name":"Drug Enforcement Administration","id":116,"url":"https://www.federalregister.gov/agencies/drug-enforcement-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/116","parent_id":268,"slug":"drug-enforcement-administration"}],"excerpts":"Groff Health Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information."},{"title":"Importer of Controlled Substances Application: DMS Pharmaceutical Group","type":"Notice","abstract":"DMS Pharmaceutical Group has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.","document_number":"2026-21354","html_url":"https://www.federalregister.gov/documents/2026/10/19/2026-21354/importer-of-controlled-substances-application-dms-pharmaceutical-group","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2026-10-19/pdf/2026-21354.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2026-21354.pdf?1792154724","publication_date":"2026-10-19","agencies":[{"raw_name":"DEPARTMENT OF JUSTICE","name":"Justice Department","id":268,"url":"https://www.federalregister.gov/agencies/justice-department","json_url":"https://www.federalregister.gov/api/v1/agencies/268","parent_id":null,"slug":"justice-department"},{"raw_name":"Drug Enforcement Administration","name":"Drug Enforcement Administration","id":116,"url":"https://www.federalregister.gov/agencies/drug-enforcement-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/116","parent_id":268,"slug":"drug-enforcement-administration"}],"excerpts":"DMS Pharmaceutical Group has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information."}]}